Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3514-3515. doi: 10.1210/jc.2018-01340.
A new gain-of-function CASR mutation has been described as a cause of hypocalcemia. This mutation, unlike other such mutations, is inherited recessively and has implications in genetic evaluation.
一个新的功能获得性 CASR 突变被描述为低钙血症的一个原因。与其他此类突变不同,该突变是隐性遗传的,这对遗传评估有影响。